Reducing pancreatic enzyme dose does not compromise growth in cystic fibrosis
- 1 December 1998
- journal article
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 11 (6) , 487-492
- https://doi.org/10.1046/j.1365-277x.1998.00130.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementationArchives of Disease in Childhood, 1998
- High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic FibrosisNew England Journal of Medicine, 1997
- Polymorphism at the tumour necrosis factor locus: a marker of genetic predisposition to colorectal cancer?The Lancet, 1994
- Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymesThe Lancet, 1994
- A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.Archives of Disease in Childhood, 1993
- Digestive and Absorptive Phase Anomalies Associated with the Exocrine Pancreatic Insufficiency of Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1988
- A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and TorontoJournal of Clinical Epidemiology, 1988
- Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.Thorax, 1987
- Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorptionThe Journal of Pediatrics, 1982